2012RDPAC_Code_of_Practice药品推广行为准则2016版.pdf

RDPAC药品推广行为准则 （2012年修订版） RDPAC Code of Practice 2012 中国外商投资企业协会药品研制和 开发行业委员会 China Association of Enterprises with Foreign Investment RD-Based Pharmaceutical Association Committee 主席致辞 Chairman’s Message会 协 业 企 药 制 发 开 制 研 中国政府在医疗卫生体制改 The Chinese Government’s vision 革一系列政策及最新公布的十二五 and commitment to significantly im- prove the wellness of the Chinese 计划中明确表达了其将大大改善中 people are well articulated in the 国人民福祉的宏伟规划与承诺。其 new healthcare reform policy and the 中，加强疾病预防，改善医疗卫生 recently issued National 12th 5-Year 服务的可及性和扩大基本医疗保险 Plan. A renewed focus on preven- tion, access and insurance coverage 的覆盖率等举措将对整个中国医疗 will fundamentally impact the posi- 卫生体系向积极的方向发展产生根 tive rate of change in the healthcare 本的影响。 environment. 与此同时，医疗卫生领域各 Concurrently, it is imperative that 相关方面，包括制药行业自身， all stakeholders, including Industry itself, reinforce the Government’s 都应当以严格遵守最高职业和伦理 commitment by adhering to the high- 道德标准的行为规范的方式来响 est standards of professional and 应政府的这一宏伟规划和承诺。 ethical conduct. RDPAC with the 2006年，RDPAC在IFPMA的支持 support and guidance from IFPMA 与指导下修改了行业的推广行为准 has established its Code of Con- duct in 2006 and now has further 则； 而2012年，我们在更加深入 strengthened it in its 2012 update 地了解患者和其他利益相关方需求 after closely listening to patients and 的基础上，即将进一步强化行业的 our stakeholders. Our Industry has 推广行为准则。研发制药行业的贡 been highly recognized, yet we real- 献有目共睹，但我们也意识到，只 ize that trust is s